Abstract:Diabetic kidney disease (DKD) is diagnosed increasingly frequently and represents a serious threat to human health. Kruppel-like factor 4 (KLF4) has aroused attention due to its potential effect on podocytes and in ameliorating proteinuria associated with glomerulopathy. The purpose of the present study was to investigate the potential role of KLF4 in DKD. It was hypothesized that KLF4 impacts diabetic nephropathy by mediating the podocyte autophagic process. A KLF4 plasmid vector was constructed, and podocytes were transfected and incubated with DKD mice serum for in vitro experiments. A db/db spontaneous DKD mouse model was also established for in vivo study. After treatment, the level of serum creatinine (Scr), blood urea nitrogen (BUN), and 24-h urinary protein was determined. Immunofluorescence and periodic acid-Schiff staining, western blotting, flow cytometry and a TUNEL assay were performed to observe changes in glomerular morphology and the level of apoptosis, cytoskeleton proteins, epithelial-mesenchymal transition (EMT) biomarkers, autophagic proteins and mTOR pathway proteins in each group. KLF4 overexpression significantly reduced the level of urinary albumin, Scr, BUN and attenuated mesangial matrix expansion, as well as mesangial cell proliferation in DKD mice. KLF4 overexpression also inhibited podocyte apoptosis and downregulated vimentin and alpha-smooth muscle actin, and upregulated E-cadherin and nephrin, both in vivo and in vitro. Moreover, the microtubule associated protein 1 light chain 3 alpha (LC3)-II/LC3-I ratio and LC3-II fluorescence was significantly increased in the vector-KLF4 group compared to the negative control vector group both in vivo and in vitro. Finally, a decrease in the level of phosphorylated (p)-mTOR and p-S6K protein expression was observed following KLF4 overexpression in vitro. The present findings suggested that KLF4 plays a renoprotective role in DKD, which is associated with the activation of podocyte autophagy, and may be involved in the mTOR signaling pathway.

Krϋppel-like factors (KLFs) in renal physiology and disease

Krüppel-like Factor 15: A Potential Therapeutic Target for Kidney Disease

Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.

Roles of Krüppel‐like factor 5 in kidney disease

Low-protein Diet Supplemented with Ketoacids Reduces the Severity of Renal Disease in 5/6 Nephrectomized Rats: a Role for KLF15

Exploring the Functionality of the Krüppel-like Factors in Kidney Development, Metabolism, and Diseases

Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease

Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy

Krüppel-like factors family in health and disease

The Role of Krüppel-like Factor 4 in Renal Fibrosis

Targeting KLF2 As a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease

Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2*

The kruppel-like factor (KLF) family, diseases, and physiological events

KLF transcription factors in bone diseases

Krüppel-like factors in bone biology

Kruppel-Like Factor 2 Regulates Endothelial Barrier Function

Krüppel-like factors in tumors: Key regulators and therapeutic avenues

The role of KLF transcription factor in the regulation of cancer progression

KLF11 deficiency enhances chemokine generation and fibrosis in murine unilateral ureteral obstruction

Krüppel-like factors: three fingers in control

Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease